Tatjana Stankovic

1 - 20 out of 78Page size: 20

Publications

  1. 2020
  2. Published

    Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity

    Tatjana Stankovic, Angelo Agathanggelou & John Fossey, 27 Nov 2020, In: Tetrahedron. 76, 48, 131631.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Genetics in the era of targeted CLL therapy

    Tatjana Stankovic & Marwan Cheng Kuang Kwok, 25 Jun 2020, In: Blood. 135, 26, p. 2333-2334 2 p.

    Research output: Contribution to journal › Comment/debate › peer-review

  4. Published

    Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL: natural history and mechanism of spontaneous CLL regression

    Marwan Cheng Kuang Kwok, Ceri Oldreive, Anshita Goel, Grigorios Papatzikas, Samantha Drennan, Angelo Agathanggelou, Archana Sharma-Oates, Robert Hollows, Nick Davies, Helen Parry, Andrew Beggs & 10 others, , Malcolm Taylor, Jean-Baptiste Cazier, Paul Moss & Tatjana Stankovic, 6 Feb 2020, In: Blood. 135, 6, p. 411-428 18 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2019
  6. Published

    Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia

    Helen Parry, Jianmin Zuo, Heather Long, Marwan Cheng Kuang Kwok, Tatjana Stankovic & Paul Moss, 12 Dec 2019, In: Frontiers in immunology. 10, 2832.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

    Ruth Roberts & 4 others, Tatjana Stankovic, John Fossey & Angelo Agathanggelou, 1 Aug 2019, In: Medchemcomm. 10, 8, p. 1379-1390 12 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    PALB2 variant status in hematological malignancies - a potential therapeutic target?

    Ceri Oldreive, Philip Byrd, Grant Stewart, Malcolm Taylor, Manoj Raghavan, Nick Davies, Marwan Cheng Kuang Kwok, Dickens Pratt, Paul Moss, Tatjana Stankovic & Malcolm Taylor, 7 Jan 2019, In: Leukemia and Lymphoma. 60, 7, p. 1823-1826 4 p.

    Research output: Contribution to journal › Letter › peer-review

  9. Published

    Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Johnson, D. E. (ed.). Elsevier, Vol. 3. p. 203-230

    Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review

  10. 2018
  11. Published

    Targeting Replication Stress in Sporadic Tumours

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 4 Sep 2018, DNA Repair and Replication: Mechanisms and Cinical Significance. Grand, R. J. A. & Reynolds, J. J. (eds.). 1st ed. CRC Press, p. 329-340 22 p.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review

  12. Published

    A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

    Christina Yap, Ceri Oldreive, Daniel Slade, Paul Moss & Tatjana Stankovic, Aug 2018, In: British Journal of Haematology. 182, 3, p. 429-433

    Research output: Contribution to journal › Letter › peer-review

  13. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 4 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukaemia (ALL) cells to cytotoxic agents and involves down-regulation of STAT6 and PDAP1

    Wenbin Wei, Tatjana Stankovic & Pamela Kearns, 1 Jul 2018, In: Experimental Hematology. 63, p. 52-63.e5

    Research output: Contribution to journal › Article › peer-review

  15. 2017
  16. Published

    USP7 inhibition alters homologous recombination repair and targets CLL cells independent of ATM/p53 functional status

    Angelo Agathanggelou, Nick Davies, Marwan Cheng Kuang Kwok, Anastasia Zlatanou, Ceri Oldreive, Tracey Perry, Pamela Kearns, Anna Skowronska, Helen Parry, Dickens Pratt, Paul Moss & 3 others, Malcolm Taylor, Grant Stewart & Tatjana Stankovic, 11 May 2017, In: Blood.

    Research output: Contribution to journal › Article › peer-review

  17. Published

    Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts

    Nick Davies, Marwan Cheng Kuang Kwok, Ceri Oldreive, Helen Parry, Angelo Agathanggelou, Dickens Pratt, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 26 Apr 2017, In: OncoTarget. 8, 27, p. 44749-44760

    Research output: Contribution to journal › Article › peer-review

  18. 2016
  19. Published

    NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma

    Helen Parry, Ceri Oldreive, Tatjana Stankovic, Dickens Pratt, Jianmin Zuo & Paul Moss, 17 Sep 2016, In: OncoTarget. 7, p. 68513-68526

    Research output: Contribution to journal › Article › peer-review

  20. Published

    A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development

    Philip Byrd, Grant Stewart, Malcolm Taylor, James Last, Tatjana Stankovic & Malcolm Taylor, 18 Mar 2016, In: PLoS Genetics. 12, 3, e1005945.

    Research output: Contribution to journal › Article › peer-review

  21. Published

    ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, Ceri Oldreive, Eva Petermann, Grant Stewart, Dickens Pratt, Helen Parry, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 4 Feb 2016, In: Blood. 127, 5, p. 582-595

    Research output: Contribution to journal › Article › peer-review

  22. E-pub ahead of print

    Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

    Tatjana Stankovic, Ceri Oldreive & 6 others, , 2 Feb 2016, In: Blood.

    Research output: Contribution to journal › Article › peer-review

  23. 2015
  24. Published

    Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

    Ceri Oldreive, Nick Davies, Anna Skowronska, Marwan Cheng Kuang Kwok, Paul Moss, Michael Griffiths, Malcolm Taylor & Tatjana Stankovic, 3 Dec 2015, Blood. American Society of Hematology, Vol. 126. p. 167 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  25. Published

    T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice

    Ceri Oldreive, Nick Davies, Helen Parry, Angelo Agathanggelou, Laura Cronin, Katerina Vrzalikova, Elena Odintsova, Dickens Pratt, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 28 Oct 2015, In: Disease Models and Mechanisms. 8, p. 1401-1412 12 p.

    Research output: Contribution to journal › Article › peer-review

  26. Published

    Targeting the ataxia telangiectasia mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants

    Angelo Agathanggelou, Victoria Weston, Tracey Perry, Nick Davies, John Fossey, Ceri Oldreive, Wenbin Wei, Dickens Pratt, Paul Moss, Grant Stewart, Malcolm Taylor & 1 others, Tatjana Stankovic, 31 Aug 2015, In: Haematologica. 100, 8, p. 1076-1085 10 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 Next